Speakers

Ron Mazumder, PhD, MBA

Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics
Genentech, Inc.

Session

The Next Generation: Evolving Business Models for Companion Diagnostics
Business Model Panel Discussion – Companion Diagnostics
1:50 PM - 2:35 PM

 

Abhijit “Ron” Mazumder obtained his B.A. from The Johns Hopkins University, his PhD from the University of Maryland, and his MBA from Lehigh University. After working in several biotech companies, he joined Johnson & Johnson in 2003 and led molecular diagnostics programs and biomarker collaborations. In 2008, he joined Merck as a Senior Director and Biomarker Leader in External Discovery where he was responsible for the development of pharmacodynamic and predictive biomarkers. Ron rejoined Johnson & Johnson in 2010 and led the development of companion and complementary diagnostics across the therapeutic pipeline. In October 2016, he joined Genentech where he is currently Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics.